Noxopharm Limited (ASX:NOX)
Australia · Delayed Price · Currency is AUD 0.0880
+0.0090 (11.39%)
Aug 5, 2026, 12:10 PM AEST
Noxopharm Market Cap
Noxopharm has a market cap or net worth of 27.04 million as of August 5, 2026. Its market cap has decreased by -19.55% in one year.
Market Cap
27.04M
Enterprise Value
31.19M
Revenue
3.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 27.04M, an increase of 94.42%. That is a compound annual growth rate of 6.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 27.04M | -0.52% |
| Dec 31, 2025 | 27.18M | - |
| Dec 31, 2024 | 27.18M | 30.99% |
| Dec 29, 2023 | 20.75M | -51.03% |
| Dec 30, 2022 | 42.37M | -62.82% |
| Dec 31, 2021 | 113.97M | -9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurizon Therapeutics | 46.27M |
| Imugene | 34.93M |
| Algorae Pharmaceuticals | 24.31M |
| NeuroScientific Biopharmaceuticals | 23.38M |
| EZZ Life Science Holdings | 22.59M |
| Proteomics International Laboratories | 22.30M |
| Patrys | 22.00M |
| Neurotech International | 21.08M |